Healthy Beginnings

Feds Fund Groundbreaking $7 million Chelation Heart Study


Chelation therapy is an IV therapy that has been recommended by the American Medical Association for almost 100 years for the removal

of heavy metals from the body. It has also been used by alternative medical doctors for the removal of blockages in the heart and brain blood vessels, and has been dismissed by conventional heart doctors as “fringe medicine.”

The National Institutes of Health (NIH) announced that it is approving a grant
of $37 million to conduct a follow-up study of promising preliminary research. This research suggests that chelation therapy may be as beneficial as the use of conventional medication and treatments – or more so – in preventing heart attacks.

The lead researcher is Dr. Gervasio Lamas, chief cardiologist with the Columbia University Division of Cardiology at Mount Sanai Medical Center in Miami Beach.

The study, known as the Trial to Assess Chelation Therapy 2 (TACT2), will involve 1,200 patients and is being conducted with the Duke Clinical Research Institute and other leading medical institutions.

If TACT2 is positive, it will forever change the way we treat heart attack patients and view toxic metals in the environment. Dr. Lamas has noted that, “chelation therapy cleanses the body of environmental pollutants that may be implicated in heart disease.”

The research aims to examine the use
of intravenous chelation treatments in combination with oral vitamins in diabetic patients with a history of a prior heart attack.

The goal is to determine if chelation can prevent recurrent heart episodes such as heart attacks, stroke, death and others by removing toxins from the blood.

Chelation has long been approved by
the U.S. Food and Drug Administration
to rid the body of toxic heavy metals
by using a synthetic amino acid (ethylenediaminetetraacetic acid, or EDTA), which binds to toxic metals and minerals in the bloodstream, allowing them to be excreted in the urine.

Some experts believe heavy metal contamination is linked to heart disease. Chelation rids the body of deposits that can lead to atherosclerosis, which causes coronary arteries to narrow, leading to heart attacks.

Dr. Lamas, who once dismissed chelation as “quackery,” began looking into its potential benefits 14 years ago. In 2002, he launched an NIH sponsored study involving more than 1,700 heart attack survivors
at 134 research sites across the U.S. and Canada.

Over a 7-year period, the participants
were randomly assigned to receive 40 injections of a chelation solution or an inactive placebo. The results showed that those who received chelation plus vitamin supplements had a 26 percent lower risk of heart complications (such as a second heart attack, stroke or bypass surgery), compared to those given a placebo.

He says, “if this study is positive, as the last one was, we will move to chelation of toxic metals as front-line therapy for heart disease!”

Alternative practitioners have used chelation therapy for nearly 60 years in the absence of clinical trial data supporting its use.

Because of the lack of such data, it has been believed by conventional medical practitioners and cardiologists to be without value

For more information, contact Reno Integrative Medical Center, 6110 Plumas St., Ste. B, Reno, NV, 89519, at 775-829-1009 or visit

References therapy-alternative